MedTrace Logo

Tenecteplase REperfusion in Acute Ischemic sTroke Registry（TREAT）

NCT05724342 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2023-02-15

No results posted yet for this study

Summary

The aim of the study was to establish tenecteplase thrombolysis database and to investigate the effectiveness and safety of rhTNK-tPA in acute ischemic stroke patients.

Conditions

  • Stroke, Ischemic

Interventions

DRUG

rhTNK-tPA Thrombolysis

rhTNK-tPA Thrombolysis

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER

  • Beijing Municipal Administration of Hospitals

    collaborator OTHER_GOV

  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Yunyun Xiong, MD, PhD · Beijing Tiantan Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05724342 on ClinicalTrials.gov